These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23351880)

  • 1. Echocardiographic integrated backscatter for detecting progression and regression of aortic valve calcifications in rats.
    Roosens B; Bala G; Gillis K; Remory I; Droogmans S; Somja J; Delvenne E; De Nayer J; Schiettecatte J; Delvenne P; Lancellotti P; Van Camp G; Cosyns B
    Cardiovasc Ultrasound; 2013 Jan; 11():4. PubMed ID: 23351880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic integrated backscatter for assessing reduction of aortic valve calcifications by R-568 in a rat model of chronic kidney disease.
    Roosens B; Bala G; Droogmans S; Hostens J; Somja J; Delvenne E; Schiettecatte J; Delvenne P; Caveliers V; Lahoutte T; Van Camp G; Cosyns B
    Ultrasound Med Biol; 2013 Nov; 39(11):2075-83. PubMed ID: 23932280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echocardiographic integrated backscatter for the differentiation between aortic valve calcification and valvular myxoid degeneration in rats.
    Gillis K; Bala G; Roosens B; Remory I; De Raeve H; Tierens S; Hernot S; Van Camp G; Droogmans S; Cosyns B
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1042-7. PubMed ID: 24787702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of renal failure and dyslipidaemia in the development of calcific aortic valve disease in rats.
    Gillis K; Roosens B; Bala G; Remory I; Hernot S; Delvenne P; Mestrez F; Droogmans S; Cosyns B
    Acta Cardiol; 2017 Oct; 72(5):537-546. PubMed ID: 28657494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated backscatter for the in vivo quantification of supraphysiological vitamin D(3)-induced cardiovascular calcifications in rats.
    Roosens B; Droogmans S; Hostens J; Somja J; Delvenne E; Hernot S; Bala G; Degaillier C; Caveliers V; Delvenne P; Lahoutte T; Van Camp G; Cosyns B
    Cardiovasc Toxicol; 2011 Sep; 11(3):244-52. PubMed ID: 21667188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.
    Jung JJ; Razavian M; Challa AA; Nie L; Golestani R; Zhang J; Ye Y; Russell KS; Robinson SP; Heistad DD; Sadeghi MM
    J Nucl Med; 2015 Jun; 56(6):933-8. PubMed ID: 25908827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of cardiovascular calcifications in normal, aging rats.
    Roosens B; Bala G; Droogmans S; Hostens J; Somja J; Delvenne E; Schiettecatte J; Delvenne P; Lahoutte T; Van Camp G; Cosyns B
    Exp Gerontol; 2012 Aug; 47(8):614-9. PubMed ID: 22634235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Label-free optical biomarkers detect early calcific aortic valve disease in a wild-type mouse model.
    Tandon I; Johns S; Woessner A; Perez J; Cross D; Ozkizilcik A; Muldoon TJ; Vallurupalli S; Padala M; Quinn KP; Balachandran K
    BMC Cardiovasc Disord; 2020 Dec; 20(1):521. PubMed ID: 33308143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive aortic valve calcification: three-dimensional visualization and biomechanical analysis.
    Halevi R; Hamdan A; Marom G; Mega M; Raanani E; Haj-Ali R
    J Biomech; 2015 Feb; 48(3):489-97. PubMed ID: 25553668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Serum Leptin Level and Calcific Aortic Valve Disease.
    Liu Y; Gu Y; Shen Y; Lin B; Li Y; He X; Zhang Y; Lu L; Shen W; Zhang Q; Yang K
    J Am Heart Assoc; 2019 Oct; 8(19):e012495. PubMed ID: 31566104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperphosphatemia is required for initiation but not propagation of kidney failure-induced calcific aortic valve disease.
    Shuvy M; Abedat S; Eliaz R; Abu-Rmeileh I; Abu-Snieneh A; Ben-Dov IZ; Meir K; Pereg D; Beeri R; Lotan C
    Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H695-H704. PubMed ID: 31398059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raloxifene attenuates Gas6 and apoptosis in experimental aortic valve disease in renal failure.
    Shuvy M; Abedat S; Beeri R; Valitsky M; Daher S; Kott-Gutkowski M; Gal-Moscovici A; Sosna J; Rajamannan NM; Lotan C
    Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1829-40. PubMed ID: 21335463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic valve calcification in mild primary hyperparathyroidism.
    Iwata S; Walker MD; Di Tullio MR; Hyodo E; Jin Z; Liu R; Sacco RL; Homma S; Silverberg SJ
    J Clin Endocrinol Metab; 2012 Jan; 97(1):132-7. PubMed ID: 22031523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of valvular calcification on the diagnostic accuracy of transesophageal echocardiography for the detection of congenital aortic valve malformation.
    Makkar A; Siddiqui TS; Stoddard MF; Lewis RK; Dawn B
    Echocardiography; 2007 Aug; 24(7):745-9. PubMed ID: 17651104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo assessment of valve thickness/calcification of patients with calcific aortic stenosis in relation to in vivo clinical outcomes.
    Cheng CL; Chang HH; Huang PJ; Wang WC; Lin SY
    J Mech Behav Biomed Mater; 2017 Oct; 74():324-332. PubMed ID: 28651163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of osteopontin levels for the identification of asymptomatic patients with calcific aortic valve disease.
    Grau JB; Poggio P; Sainger R; Vernick WJ; Seefried WF; Branchetti E; Field BC; Bavaria JE; Acker MA; Ferrari G
    Ann Thorac Surg; 2012 Jan; 93(1):79-86. PubMed ID: 22093695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NFκB (Nuclear Factor κ-Light-Chain Enhancer of Activated B Cells) Activity Regulates Cell-Type-Specific and Context-Specific Susceptibility to Calcification in the Aortic Valve.
    Gee T; Farrar E; Wang Y; Wu B; Hsu K; Zhou B; Butcher J
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):638-655. PubMed ID: 31893948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the use of biomarkers in calcific aortic valve disease.
    Beckmann E; Grau JB; Sainger R; Poggio P; Ferrari G
    J Heart Valve Dis; 2010 Jul; 19(4):441-52. PubMed ID: 20845891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Aortic Valve Disease in Familial Hypercholesterolemic Swine: Implications for Elucidating Disease Etiology.
    Porras AM; Shanmuganayagam D; Meudt JJ; Krueger CG; Hacker TA; Rahko PS; Reed JD; Masters KS
    J Am Heart Assoc; 2015 Oct; 4(10):e002254. PubMed ID: 26508741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for progression of early- and late-stage calcific aortic valve disease in Japanese: the Japanese Aortic Stenosis Study (JASS) Retrospective Analysis.
    Yamamoto K; Yamamoto H; Yoshida K; Kisanuki A; Hirano Y; Ohte N; Akasaka T; Takeuchi M; Nakatani S; Ohtani T; Sozu T; Masuyama T
    Hypertens Res; 2010 Mar; 33(3):269-74. PubMed ID: 20057483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.